Posts by: Leonor Mateus Ferreira

Leonor Mateus Ferreira

Leonor Mateus Ferreira is an emerging, young journalist, with a Batchelor's degree in Communication and post-graduate degree in Multiplatform Journalism. She is particularly interested in politics and current affairs, and is currently studying for a masters degree in economics and public policies.

May 29, 2015November 5, 2015

Aeolus to Present Lung-ARS & IPF Therapy AEOL 10150 at Upcoming Conference

Idiopathic Pulmonary Fibrosis, News

Aeolus Pharmaceuticals, Inc. has been invited to present data on the progress of the company’s contract with the Biomedical Advanced Research and Development Authority (BARDA) at the upcoming LD Micro Invitational Conference. ... Read more

May 27, 2015November 6, 2015

GSK Files Application For Eosinophilic Asthma Therapy in Japan

Asthma, News

GlaxoSmithKline has filed a regulatory application to the Japanese Ministry of Health, Labor and Welfare (MHLW) requesting the commercialization of their asthma treatment mepolizumab. The application lists mepolizumab as an add-on maintenance ... Read more

May 21, 2015November 9, 2015

Poor, Rural US Regions Have Higher Prevalence of COPD

COPD, News

The prevalence of chronic obstructive pulmonary disease (COPD) is influenced by residency location and income, according to a research team led by Sarath Raju, MD, MPH, from the Johns Hopkins School of Medicine in ... Read more

May 18, 2015November 5, 2015

Insmed to Present on Rare Lung Disease Therapies at ATS Conference

News, Pulmonary Hypertension

Insmed Incorporated is presenting data on their therapies for rare pulmonary conditions at the American Thoracic Society‘s (ATS) 2015 International Conference, which is currently underway and will wrap up on May 20th in Denver. ... Read more

May 14, 2015November 9, 2015

Boehringer and Sutter Health Collaborate on COPD Patient Care

COPD, News

Boehringer Ingelheim and the not-for-profit network of hospitals, Sutter Health, established a five-year partnership focused on research and healthcare innovation, which will begin focusing on the treatment of chronic obstructive pulmonary disease (COPD). ... Read more

May 14, 2015May 14, 2015

RAFA Laboratories Partner With OSE Pharma On Tedopi Lung Therapy

Lung Cancer, News

French biotech company OSE Pharma SA and Israeli-based RAFA laboratories have signed an exclusive long term agreement for the investigational lung cancer medication Tedopi. The contract includes registration, marketing, distribution and sales ... Read more

May 13, 2015November 5, 2015

Vertex’s New CF Drug Combo Receives Positive FDA Recommendation

Cystic Fibrosis, News

The U.S. Food and Drug Administration (FDA) has issued a positive evaluation of ORKAMBI (lumacaftor/ivacaftor) as a recommended treatment for cystic fibrosis (CF) patients 12 years and older with two copies of the F508del mutation ... Read more

May 8, 2015November 6, 2015

NIH Reinforces Asthma Focus For World Asthma Day 2015

Asthma, News

World Asthma Day 2015 was held on May 5th, and in an effort to renew its commitment to improving knowledge on asthma as well as helping develop more effective treatments and preventing ... Read more

May 8, 2015November 5, 2015

Boehringer to Host 29 Presentations on IPF, Other Respiratory Diseases at Annual Thoracic Conference

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim Pharmaceuticals, Inc. has announced that it will participate in the 2015 American Thoracic Society (ATS) International Conference taking place between May 15 and 20 in Denver, and will present 29 abstracts on treatments for respiratory ... Read more

May 8, 2015November 5, 2015

Bellerophon’s New Scientific Board to Focus on PH Device

News, Pulmonary Hypertension

Bellerophon Therapeutics, Inc. has established a new INOpulse Scientific Advisory Board (SAB) to help develop its proprietary novel technology to treat pulmonary hypertension (PH). The board includes internationally recognized specialists in the disease ... Read more